EDMA

From Self-sufficiency
Revision as of 13:23, 17 August 2010 by Nirmos (Talk) (Removed one redundant category.)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
EDMA
File:EDMA.png
Systematic (IUPAC) name
1-(2,3-dihydro-1,4-benzodioxin-7-yl)-N-methylpropan-2-amine
Clinical data
Routes of
administration
Oral
Legal status
Legal status
Identifiers
CAS Number ?
ATC code none
PubChem CID 24257269
ChemSpider 23553090
Chemical data
Formula C12H17NO2
Molar mass 207.2694 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

3,4-Ethylenedioxy-N-methylamphetamine (EDMA; MDMC) is an entactogen drug of the amphetamine class.[1][2] It is an analogue of MDMA where the methylenedioxy ring has been replaced by an ethylenedioxy ring.[1][2] EDMA was first synthesized by Alexander Shulgin.[1] In his book PiHKAL, the dosage is listed as 150-250 mg, and the duration listed as 3–5 hours.[1] According to Shulgin, EDMA produces a bare threshold consisting of paresthesia, nystagmus, and hypnogogic imagery, with few to no other effects.[1] Scientific research has demonstrated that EDMA acts as a non-neurotoxic serotonin releasing agent with moderately diminished potency relative to MDMA, and with negligible effects on dopamine release.[2] Based on Shulgin's reports of essential inactivity at 150-250 mg, it may be more active at higher doses.

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

External links

  1. 1.0 1.1 1.2 1.3 1.4 Ann Shulgin; Alexander Shulgin (1991). Pihkal: A Chemical Love Story. Transform Press. ISBN 0-9630096-0-5. 
  2. 2.0 2.1 2.2 Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.